DNA
HEALTHCAREGinkgo Bioworks Holdings Inc - Class A
Live · NYSE · May 9, Close
What's Moving DNA Today?
No stock-specific AI insight has been generated for DNA yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$10.08
Fundamentals
Trading
DNA News
21 articles- Ginkgo Bioworks Reports First Quarter 2026 Financial Results, Completes Divestiture of Biosecurity and Continues to Scale Autonomous LabYahoo Finance·May 7, 2026
- Ginkgo Bioworks Announces Date of First Quarter 2026 Results PresentationYahoo Finance·Apr 30, 2026
- ProQR Highlights Pipeline Expansion and Multiple Upcoming Clinical Catalysts at Investor and Analyst EventGlobeNewswire Inc.·Apr 8, 2026
- How The Ginkgo Bioworks (DNA) Story Is Shifting As Analysts Revisit Growth And RiskYahoo Finance·Mar 14, 2026
- Ginkgo Bioworks Launches Ginkgo Cloud Lab, Powered by Autonomous Lab InfrastructureYahoo Finance·Mar 2, 2026
- A Look At Ginkgo Bioworks (DNA) Valuation After Earnings Update And Invaio CollaborationYahoo Finance·Mar 1, 2026
- Ginkgo Bioworks Q4 Earnings Call HighlightsMarketbeat·Feb 28, 2026
- Ginkgo Bioworks Holdings Inc (DNA) Q4 2025 Earnings Call Highlights: Strategic Shifts and ...Yahoo Finance·Feb 28, 2026
- Ginkgo Bioworks Holdings, Inc. Q4 2025 Earnings Call SummaryMoby·Feb 27, 2026
- Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of its Non-Core Biosecurity BusinessYahoo Finance·Feb 26, 2026
- Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2025 Results PresentationYahoo Finance·Feb 19, 2026
- Ginkgo Bioworks and Invaio Sciences Enter Collaboration to Develop Manufacturing Technology for Peptide-based Agricultural ProductsYahoo Finance·Feb 18, 2026
- Ginkgo Bioworks Holdings, Inc. (DNA) Stock Dips While Market Gains: Key FactsYahoo Finance·Feb 17, 2026
- Ginkgo Bioworks Holdings, Inc. (DNA) Falls More Steeply Than Broader Market: What Investors Need to KnowYahoo Finance·Feb 10, 2026
- Ginkgo, OpenAI Cut Protein Costs by 40%Yahoo Finance·Feb 6, 2026
- Ginkgo Bioworks' Autonomous Laboratory Driven by OpenAI's GPT-5 Achieves 40% Improvement Over State-of-the-Art Scientific BenchmarkYahoo Finance·Feb 5, 2026
- Why Ginkgo Bioworks Holdings, Inc. (DNA) Dipped More Than Broader Market TodayYahoo Finance·Feb 4, 2026
- Ginkgo Bioworks Holdings, Inc. (DNA) Declines More Than Market: Some Information for InvestorsYahoo Finance·Jan 29, 2026
- Ginkgo Bioworks Holdings, Inc. (DNA) Stock Drops Despite Market Gains: Important Facts to NoteYahoo Finance·Jan 23, 2026
- Ginkgo Bioworks Holdings, Inc. (DNA) Increases Despite Market Slip: Here's What You Need to KnowYahoo Finance·Jan 14, 2026
- Ginkgo Bioworks Announces Participation in the 44th Annual J.P. Morgan Healthcare ConferenceYahoo Finance·Jan 13, 2026
All 21 articles loaded
Price Data
52-Week Range
$10.08
Fundamentals
Trading
About Ginkgo Bioworks Holdings Inc - Class A
Ginkgo Bioworks Holdings (DNA) is a frontrunner in the synthetic biology industry, leveraging cutting-edge genetic engineering techniques to develop tailored bioengineered organisms for diverse applications in pharmaceuticals, agriculture, and industrial biotechnology. The company’s innovative platform enhances cellular design for manufacturing, optimizing product development and streamlining production processes. With a strong focus on solving critical global challenges, including climate change and food security, Ginkgo is well-positioned to influence multiple sectors while fostering sustainable advancements in biotechnology. As the industry evolves, Ginkgo's commitment to bio-based solutions positions it for significant growth and impact.